Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

BACKGROUND: Omalizumab is an efficient drug for patients with uncontrolled severe allergic asthma (SAA). However, little is known about the differences in omalizumab treatment outcomes among patients with different types of atopic sensitization. Here, we assessed the effect of sensitization to indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaník, Petr, Novosad, Jakub, Kirchnerová, Olga, Krčmová, Irena, Teřl, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493349/
https://www.ncbi.nlm.nih.gov/pubmed/32944035
http://dx.doi.org/10.1186/s13223-020-00479-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493349/
https://www.ncbi.nlm.nih.gov/pubmed/32944035
http://dx.doi.org/10.1186/s13223-020-00479-1

Ejemplares similares